Entrada Therapeutics, Inc. (TRDA)
11.30
+0.01
(+0.09%)
USD |
NASDAQ |
Feb 23, 16:00
11.30
0.00 (0.00%)
After-Hours: 18:06
Entrada Therapeutics Profit Margin (Quarterly) : -2.73K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| EyePoint Plc | -6.18K% |
| Vertex Pharmaceuticals, Inc. | 36.91% |
| Kodiak Sciences, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -26.01% |
| Return on Assets | -21.30% |
| Return on Invested Capital | -22.75% |
| Gross Profit Margin (Quarterly) | 25.65% |
| Operating Margin (Quarterly) | -2.92K% |
| Return on Net Operating Assets | -128.5% |